NF1 and melanoma: In most melanomas with altered NF1, a loss-of-function mutation is found, in which neurofibromin loses its ability to inactivate RAS and promotes stimulation of the RAF and its downstream targets, leading to stimulation of the MAPK pathway and consequent cell proliferation and survival [21].